ReviewCurrent treatment options in oncology2020

PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in Lymphoma.

Vladimir Sapon-Cousineau et al.PubMed ↗Publisher ↗

No numbers read from the abstract.